NPM-ALK signals through glycogen synthase kinase 3Β to promote oncogenesis

S. R.P. McDonnell, S. R. Hwang, V. Basrur, K. P. Conlon, D. Fermin, E. Wey, C. Murga-Zamalloa, Z. Zeng, Y. Zu, K. S.J. Elenitoba-Johnson, M. S. Lim

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


Anaplastic large cell lymphoma (ALCL) is the most common type of pediatric peripheral T-cell lymphoma. In 70-80% of cases, the chromosomal aberration t(2;5)(p23;q35) results in the juxtaposition of anaplastic lymphoma kinase (ALK) with nucleophosmin (NPM) and the subsequent expression of the NPM-ALK fusion protein. NPM-ALK is a chimeric tyrosine kinase, which induces numerous signaling pathways that drive proliferation and abrogate apoptosis. However, the mechanisms that lead to activation of downstream growth regulatory molecules have not been completely elucidated. Using a mass spectrometry-based phosphoproteomic screen, we identified GSK3β as a signaling mediator of NPM-ALK. Using a selective inhibitor of ALK, we demonstrated that the tyrosine kinase activity of ALK regulates the serine-9 phosphorylation of GSK3β. Expression of NPM-ALK in 293T cells led to an increase of pS 9-GSK3β (glycogen synthase kinase 3 beta) compared with kinase-defective K210R mutant NPM-ALK, but did not affect total GSK3β levels. Phosphorylation of pS 9-GSK3β by NPM-ALK was mediated by the PI3K/AKT signaling pathway. ALK inhibition resulted in degradation of GSK3β substrates Mcl-1 and CDC25A, which was recovered upon chemical inhibition of the proteasome (MG132). Furthermore, the degradation of Mcl-1 was recoverable with inhibition of GSK3β. ALK inhibition also resulted in decreased cell viability, which was rescued by GSK3β inhibition. Furthermore, stable knockdown of GSK3β conferred resistance to the growth inhibitory effects of ALK inhibition using viability and colony formation assays. pS 9-GSK3β and CDC25A were selectively expressed in neoplastic cells of ALKALCL tissue biopsies, and showed a significant correlation (P<0.001). Conversely, ALK+ALCL tissue biopsies did not show significant correlation of pS 9-GSK3β and CDC25A expression (P<0.2). Our results demonstrate that NPM-ALK regulates the phosphorylation of S 9-GSK3β by PI3K/AKT. The subsequent inhibition of GSK3β activity results in accumulation of CDC25A and Mcl-1, which confers the advantage of growth and protection from apoptosis. These findings provide support for the role of GSK3β as a mediator of NPM-ALK oncogenesis.

Original languageEnglish (US)
Pages (from-to)3733-3740
Number of pages8
Issue number32
StatePublished - Aug 9 2012


  • ALCL
  • GSK3
  • oncogenesis

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics


Dive into the research topics of 'NPM-ALK signals through glycogen synthase kinase 3Β to promote oncogenesis'. Together they form a unique fingerprint.

Cite this